Winning the go-to-market game: Standing out in tomorrow’s complex healthcare ecosystems
Ahead of Reuters Pharma 2022, Antonio Iervolino, Partner out of our Putnam London office describes 5 major shifts that pharma companies will have to embrace as they design the path to market for their novel assets and provides an analysis on pharma product launches since 2018, identifying trends and measuring their performance against pre-launch expectations.
Antonio distills the key drivers that are critical in developing a virtuous value creating system and designing impactful go-to-market strategies for tomorrow’s healthcare ecosystems.
Read more on the thoughtful analysis and hear from Antonio at Pharma 2022 next week.
Jump to a slide with the slide dots.
Rudiger Papsch
MAPS EMEA 2025: Driving Transformation and Excellence in Medical Affairs
Explore how MAPS EMEA 2025 redefined Medical Affairs - patient-centricity, AI, evidence generation & launch excellence take center stage
Read more
Jo Ann Saitta
Why AI Needs Humans: The Critical Thinking Advantage in Pharmaceutical Commercialization
AI speeds pharma insights, but human experts turn them into action. ClarityNav blends AI power with strategic, real-world expertise.
Read more
Radosław Skowron
Acceptance of Artificial Intelligence in Evidence and Dossier Developments by HTA bodies: Challenges and Opportunities
AI is transforming Health Technology Assessment, but trust, transparency, and clear HTA guidance are key to broader acceptance.
Read more